Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9 GBX | -10.00% | -25.00% | -59.09% |
Apr. 19 | Redx Pharma shareholders approve AIM delisting plans | AN |
Apr. 19 | Redx Pharma Gets Shareholder Approval for Delisting from AIM | MT |
Business Summary
Number of employees: 101
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Research Collaboration
96.4
%
| 7 | 36.7 % | 4 | 96.4 % | -40.91% |
Research and Preclinical Development Services
3.6
%
| 1 | 6.1 % | 0 | 3.6 % | -86.64% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Ireland
100.0
%
| 12 | 64.2 % | 4 | 100.0 % | -65.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lisa Anson
CEO | Chief Executive Officer | - | 18-05-31 |
Peter J. Collum
DFI | Director of Finance/CFO | - | 21-05-04 |
Chief Operating Officer | 46 | 18-11-18 | |
Richard E. Armer
CTO | Chief Tech/Sci/R&D Officer | - | 11-12-31 |
Nischal Hindia
SEC | Corporate Secretary | - | - |
Andrew Booth
AUD | Comptroller/Controller/Auditor | - | 15-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 22-01-26 |
Joseph Anderson
BRD | Director/Board Member | 65 | 23-09-05 |
Peter Presland
BRD | Director/Board Member | 75 | 17-11-02 |
Director/Board Member | 65 | 15-12-31 | |
Jane Griffiths
CHM | Chairman | 69 | 21-11-30 |
Lisa Anson
CEO | Chief Executive Officer | - | 18-05-31 |
Chief Operating Officer | 46 | 18-11-18 | |
Natalie Berner
BRD | Director/Board Member | 34 | 21-05-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 388,985,916 | 317,881,100 ( 81.72 %) | 0 | 81.72 % |
Company contact information
Redx Pharma Plc
Alderley Park Mereside
SK10 4TG, Macclesfield
+44 16 2546 9900
http://www.redxpharma.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-59.09% | 43.61M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- REDX Stock
- Company Redx Pharma Plc